Keller Deborah L 4

What Happened

• Deborah L. Keller, a director of West Pharmaceutical Services, Inc. (WST), received an award of 791 restricted stock units (RSUs) on 2026-05-04. The RSUs were reported at $0.00 per share (an equity award, not a market purchase), resulting in $0 cash paid at grant.

Key Details

• Transaction date: 2026-05-04; Form 4 filed: 2026-05-06.
• Transaction code: A (grant/award).
• Shares/units granted: 791 RSUs; reported price: $0.00.
• Shares owned after transaction: not specified in the provided filing.
• Footnote: These RSUs "will vest in full on the date of the next annual shareholder meeting" (per footnote F1).
• Filing appears to report the grant (not a sale or purchase); no 10b5-1, tax-withholding, or exercise activity noted.

Context

• This is an equity award to a non-executive director and is a routine form of compensation rather than an open-market investment signal. The RSUs vest at the stated future date, at which point they may convert to shares subject to company plan terms and any withholding.